communicable disease

Kitsap Respiratory Illness Report: 10/27/24-11/2/24

View this report as an interactive dashboard. In week ending November 2, local indicators for COVID-19 and respiratory syncytial virus (RSV) remained minimal. Influenza indicators remained low but showed signs that local flu activity is beginning to rise. Regional laboratory data are most frequently detecting rhinovirus among clinical respiratory specimens. 0.7% of emergency department (ED) visits were Kitsap Respiratory Illness Report: 10/27/24-11/2/24

Health Advisory: 2024-2025 COVID-19 vaccines approved

ACTIONS REQUESTED  BE AWARE that updated (2024–2025) COVID-19 vaccines have been approved and authorized by the FDA. The new formulations provide better protection against currently circulating COVID-19 variants. For more information, see: DISCONTINUE USE of the 2023–2024 Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines. These formulations are no longer authorized by the FDA. BE AWARE that there are two types Health Advisory: 2024-2025 COVID-19 vaccines approved

TB on the Radar: A tuberculosis presentation for Kitsap healthcare providers

On June 13, 2024, Kitsap Public Health District presented “TB on the Radar,” a special public health presentation highlighting the ongoing risk from tuberculosis (TB), public health response to TB, and healthcare best practices for testing, diagnosis, and treatment of TB. The presentation featured insights from local and state TB experts and a Q&A with panelists.  TB on the Radar: A tuberculosis presentation for Kitsap healthcare providers